This company has been marked as potentially delisted and may not be actively trading. NASDAQ:IMRA IMARA (IMRA) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsInsider TradesTrendsBuy This Stock About IMARA Stock (NASDAQ:IMRA) 30 days 90 days 365 days Advanced Chart Get IMARA alerts:Sign Up Key Stats Today's Range$55.64▼$55.6450-Day Range$6.32▼$25.2852-Week Range$0.97▼$6.32Volume48 shsAverage Volume138,364 shsMarket Capitalization$1.46 billionP/E Ratio1,112.93Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewIMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2-related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.Read More… Receive IMRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IMARA and its competitors with MarketBeat's FREE daily newsletter. Email Address IMRA Stock News HeadlinesImran Khan opens up on his comparisons to Ranbir Kapoor: 'I never considered...'May 11, 2024 | msn.comImara BlumeAugust 23, 2023 | health.usnews.com$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.April 26, 2025 | Stansberry Research (Ad)IMARA Inc. (IMRA) Stock Historical Prices & Data - Yahoo FinanceMarch 3, 2023 | finance.yahoo.comImara Announces Stockholder Approval of Merger With EnlivenFebruary 22, 2023 | finance.yahoo.comSHAREHOLDER ALERT: Weiss Law Reminds IMRA, TIG, FORG, and BRBW Shareholders About Its Ongoing InvestigationsJanuary 5, 2023 | benzinga.comImara 10% Owner Trades $336K In Company StockOctober 25, 2022 | benzinga.com$1.9 Million Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying - Imara - BenzingaOctober 20, 2022 | benzinga.comSee More Headlines IMRA Stock Analysis - Frequently Asked Questions How were IMARA's earnings last quarter? IMARA Inc. (NASDAQ:IMRA) posted its quarterly earnings data on Tuesday, November, 9th. The company reported ($2.20) earnings per share (EPS) for the quarter, beating the consensus estimate of ($3.64) by $1.44. When did IMARA's stock split? IMARA's stock reverse split before market open on Friday, February 24th 2023. The 1-4 reverse split was announced on Friday, February 24th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. When did IMARA IPO? IMARA (IMRA) raised $76 million in an initial public offering (IPO) on Thursday, March 12th 2020. The company issued 4,500,000 shares at $16.00-$18.00 per share. Morgan Stanley, Citigroup and SVB Leerink acted as the underwriters for the IPO. What other stocks do shareholders of IMARA own? Based on aggregate information from My MarketBeat watchlists, some other companies that IMARA investors own include NIO (NIO), Novavax (NVAX), NVIDIA (NVDA), Axsome Therapeutics (AXSM), Alibaba Group (BABA), AMC Entertainment (AMC) and BioXcel Therapeutics (BTAI). Company Calendar Last Earnings11/09/2021Today4/26/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:IMRA CIK1672619 Webwww.imaratx.com PhoneN/AFaxN/AEmployees41Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.05 Trailing P/E Ratio1,112.93 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.49 million Net MarginsN/A Pretax MarginN/A Return on Equity2.12% Return on Assets2.00% Debt Debt-to-Equity RatioN/A Current Ratio48.98 Quick Ratio48.98 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.74 per share Price / Cash Flow75.24 Book Value$3.44 per share Price / Book16.17Miscellaneous Outstanding Shares26,234,000Free Float16,449,000Market Cap$1.46 billion OptionableNot Optionable Beta1.09 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:IMRA) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMARA Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IMARA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.